Stool DNA Tests Offer Higher Sensitivity but Lower Specificity Than FIT Skip to content The CRC Digest Stool DNA Tests Offer Higher Sensitivity but Lower Specificity Than FIT Multitarget stool DNA tests show higher sensitivity for colorectal cancer and advanced adenomas than FIT, but with lower specificity and higher costs; further evidence is needed on long-term effectiveness and economic sustainability. (Clinical
Symptom Identification Critical for Adults 18-44 Skip to content The CRC Digest Symptom Identification Critical for Adults 18-44 Adults under 45 without access to average-risk screening require a well-defined system for symptom identification and workup to avoid diagnostic delays and worse outcomes. (Cancer Epidemiology, Biomarkers & Prevention) This content is informational only and does not constitute
FIT Remains Cornerstone of Population-Based CRC Screening Skip to content The CRC Digest ▪ SCREENING FIT Remains Cornerstone of Population-Based CRC Screening Fecal immunochemical testing (FIT) continues to be the foundation of organized colorectal cancer screening programs due to its noninvasive nature, affordability, and proven mortality reduction, though stool DNA tests may serve as complementary options in hybrid
Study Examines Symptoms as Diagnostic Indicators in Adults Under 45 Skip to content The CRC Digest ▪ SCREENING Study Examines Symptoms as Diagnostic Indicators in Adults Under 45 (Cancer Epidemiology, Biomarkers & Prevention) This content is informational only and does not constitute medical advice. Always consult your oncologist or care team. © 2026 The CRC Digest — crcdigest.com
Unexplained Microcytosis in 40-Year-Old: Missed Opportunity for Early Diagnosis Skip to content The CRC Digest Unexplained Microcytosis in 40-Year-Old: Missed Opportunity for Early Diagnosis A case report highlights how isolated microcytosis and iron deficiency in a 40-year-old male with morbid obesity was a missed early indicator of colorectal cancer. (South Dakota Medicine) This content is informational only and does
Gut microbiome signatures show promise for non-invasive detection of colorectal neoplasia Skip to content The CRC Digest ▪ SCREENING Gut microbiome signatures show promise for non-invasive detection of colorectal neoplasia Multinational metagenomic studies have identified reproducible microbial signatures associated with CRC, offering a potential alternative to current stool-based tests that have limited sensitivity for adenoma detection. (Journal of Gastroenterology) This content is
Multi-cancer blood tests may not match colonoscopy for colorectal cancer prevention Skip to content The CRC Digest ▪ SCREENING Multi-cancer blood tests may not match colonoscopy for colorectal cancer prevention A modeling study found that multi-cancer early detection blood tests offer little opportunity for cancer prevention through precursor lesion removal, raising questions about whether detecting multiple cancers can offset the loss of